Works about GLUCAGON-like peptide-1 agonists

Results: 2800

Response to Comment on Wong et al. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care 2025;48:292–300

Published in:

2025

By:

Wong, Hon Jen;
Sim, Bryan;
Teo, Yao Hao;
Dalakoti, Mayank;
Sia, Ching-Hui

Publication type:

Letter

Comment on Wong et al. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care 2025;48:292–300

Published in:

2025

By:

Huang, Jian

Publication type:

Letter

High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial.

Published in:

Diabetes Care, 2025, v. 48, n. 6, p. 905, doi. 10.2337/dc24-2425

By:

Aroda, Vanita R.;
Jørgensen, Nils B.;
Kumar, Bharath;
Lingvay, Ildiko;
Laulund, Anne Sofie;
Buse, John B.

Publication type:

Article

Risk of Urogenital Infections in People With Type 2 Diabetes Initiating SGLT2is Versus GLP-1RAs in Routine Clinical Care: A Danish Cohort Study.

Published in:

Diabetes Care, 2025, v. 48, n. 6, p. 945, doi. 10.2337/dc24-2169

By:

Ljungberg, Christine;
Kristensen, Frederik Pagh Bredahl;
Dalager-Pedersen, Michael;
Vandenbroucke-Grauls, Christina;
Sørensen, Henrik Toft;
Nørgaard, Mette;
Thomsen, Reimar Wernich

Publication type:

Article

Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice.

Published in:

Cardiovascular Research, 2025, v. 121, n. 3, p. 454, doi. 10.1093/cvr/cvaf005

By:

Chen, Mengya;
Zhao, Nan;
Shi, Wenke;
Xing, Yun;
Liu, Shiqiang;
Meng, Xianxian;
Li, Lanlan;
Zhang, Heng;
Meng, Yanyan;
Xie, Saiyang;
Deng, Wei

Publication type:

Article

Temporal changes in mediation effects on cardiovascular and microvascular outcomes with glucagon-like peptide-1 receptor agonist therapy: a post-hoc analysis of the LEADER trial.

Published in:

Cardiovascular Research, 2025, v. 121, n. 1, p. 10, doi. 10.1093/cvr/cvae237

By:

Peng, Zi-Yang;
Lee, Yu-Hsuan;
Ou, Huang-Tz;
Kuo, Shihchen

Publication type:

Article

Updates in chronic kidney disease management: A systematic review.

Published in:

Pharmacotherapy, 2025, v. 45, n. 5, p. 291, doi. 10.1002/phar.70014

By:

Ammar, Amina;
Edwin, Stephanie B.;
Whitney, Rachel;
Lipari, Melissa;
Giuliano, Christopher

Publication type:

Article

PERSPECTIVE.

Published in:

Ocular Surgery News, 2025, v. 43, n. 9, p. 7

By:

Mollan, Susan P.

Publication type:

Article

Semaglutide use linked with increased risk for NAION in patients with diabetes.

Published in:: Ocular Surgery News, 2025, v. 43, n. 9, p. 1
Publication type:: Article

Annals for Educators - May 2025.

Published in:

Annals of Internal Medicine, 2025, v. 178, n. 5, p. 1, doi. 10.7326/ANNALS-25-02068-ED

By:

Laine, Christine

Publication type:

Article

In adults with overweight or obesity and without diabetes, GLP-1 RAs increase weight loss vs. placebo.

Published in:

Annals of Internal Medicine, 2025, v. 178, n. 5, p. JC54, doi. 10.7326/ANNALS-25-01325-JC

By:

Lau, Darren

Publication type:

Article

Summary for Patients: Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide.

Published in:: Annals of Internal Medicine, 2025, v. 178, n. 5, p. I-18, doi. 10.7326/ANNALS-24-03849-PS
Publication type:: Article

Applicability of multiple quantitative ultrasound liver biomarkers in children and adolescents with severe obesity.

Published in:

BMC Pediatrics, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12887-025-05750-1

By:

Cetinic, Ivan;
de Lange, Charlotte;
Lagerstrand, Kerstin;
Kindblom, Jenny M.;
Sjögren, Lovisa;
Hebelka, Hanna

Publication type:

Article

Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future.

Published in:

Diabetes Therapy, 2025, v. 16, n. 6, p. 1155, doi. 10.1007/s13300-025-01738-3

By:

Fernando, Kevin;
Connolly, Derek;
Darcy, Eimear;
Evans, Marc;
Hinchliffe, William;
Holmes, Patrick;
Strain, W. David

Publication type:

Article

The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy.

Published in:

Diabetes Therapy, 2025, v. 16, n. 6, p. 1077, doi. 10.1007/s13300-025-01712-z

By:

Panou, Theodoros;
Gouveri, Evanthia;
Popovic, Djordje S.;
Papazoglou, Dimitrios;
Papanas, Nikolaos

Publication type:

Article

Cost-utility of IDegLira versus alternative basal insulin intensification therapies in patients with type 2 diabetes mellitus uncontrolled on basal insulin in a Chinese setting.

Published in:

Diabetology & Metabolic Syndrome, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13098-025-01722-8

By:

Weng, Junling;
Xiao, Dunming;
Chen, Yingyao

Publication type:

Article

GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds.

Published in:

2025

By:

Halsey, Grace

Publication type:

Abstract

GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds.

Published in:

2025

By:

Halsey, Grace

Publication type:

Abstract

Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies.

Published in:

European Heart Journal, 2025, v. 46, n. 19, p. 1849, doi. 10.1093/eurheartj/ehae931

By:

Watts, Gerald F;
Chan, Dick C

Publication type:

Article

Effects of patient age on the therapeutic effects of GIP/GLP-1 receptor agonists (tirzepatide).

Published in:

Drug Discoveries & Therapeutics, 2025, v. 19, n. 2, p. 133, doi. 10.5582/ddt.2025.01012

By:

Atsushi Ishimura;
Yutaka Shimizu;
Naohiro Yabuki

Publication type:

Article

The role of dulaglutide in the treatment of alcohol use disorder: a case report.

Published in:

Frontiers in Psychiatry, 2025, p. 1, doi. 10.3389/fpsyt.2025.1420316

By:

Hill, Olivia;
Hughes, Sarah;
Singh, Aakanksha;
Ang-Rabanes, Michael;
Mogallapu, Raja

Publication type:

Article

Impact of Prescribing Patterns Before and After Short-Term, Pharmacist-Led Type 2 Diabetes Service in an Endocrinology Clinic.

Published in:

Diabetes Spectrum, 2025, v. 38, n. 2, p. 194, doi. 10.2337/ds24-0046

By:

Parsiani, Rita;
Mendoza, Francine;
Wilson, Leah;
Joarder, Farahnaz;
Zahr, Roula;
Ahmann, Andrew;
Chen, Siting;
Lee, Haemin

Publication type:

Article

Clinical studies on anti-obesity medications in Arab countries.

Published in:

Saudi Medical Journal, 2025, v. 46, n. 5, p. 459, doi. 10.15537/smj.2025.46.5.20250126

By:

AlOtaibi, Haifa F.;
Al Taib, Hanan N.;
AlMuhaidib, Shadan;
Alshagrawi, Saud;
Almufarrih, Abdulmalik;
Alalmai, Ola;
Alnaserallah, Sahar;
Alodah, Najla;
Alqahtani, Saleh A.;
Alhazzani, Waleed

Publication type:

Article

Effects of oral antidiabetic agents on the renin–angiotensin–aldosterone system.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 6, p. 801, doi. 10.1007/s00228-025-03830-w

By:

Yang, Xifeng;
Qi, Yijie;
Hao, Jinxuan;
Wei, Hongxia;
Li, Zhe;
Xu, Ming;
Zhang, Yi;
Liu, Yunfeng

Publication type:

Article

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization.

Published in:

BMC Psychiatry, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12888-025-06914-0

By:

Zhang, Lingfeng;
Chen, Xiang;
Xu, Yantao;
Liu, Jiachen;
Liu, Zhongchun

Publication type:

Article

Exendin-4 improves cerebral ischemia by relaxing microvessels, rapidly increasing cerebral blood flow after reperfusion.

Published in:

Basic Research in Cardiology, 2025, v. 120, n. 2, p. 423, doi. 10.1007/s00395-025-01096-y

By:

Chen, Yujie;
Wang, Lei;
Zhou, Yutong;
Wang, Yuguang;
Qin, Wei;
Wang, Mingxiao;
Liu, Bo;
Tian, Qian;
Xu, Huisen;
Shen, Hui;
Zheng, Chen

Publication type:

Article

A Half Dose of Semaglutide Yields Weight Loss Equivalent to Clinical Trial Doses in Combination with Online Support Program.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Glucagon-like Peptide-1 Receptor Agonists in the Context of Eating Disorders: A Promising Therapeutic Option or a Double-Edged Sword?

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 9, p. 3122, doi. 10.3390/jcm14093122

By:

Kałas, Maria;
Stępniewska, Ewelina;
Gniedziejko, Michał;
Leszczyński-Czeczatka, Jakub;
Siemiński, Mariusz

Publication type:

Article

Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 9, p. 3083, doi. 10.3390/jcm14093083

By:

Abrignani, Maurizio Giuseppe;
Lucà, Fabiana;
Abrignani, Vincenzo;
Nucara, Mariacarmela;
Grosseto, Daniele;
Lestuzzi, Chiara;
Mistrangelo, Marinella;
Passaretti, Bruno;
Rao, Carmelo Massimiliano;
Parrini, Iris

Publication type:

Article

May Patients Receiving GLP-1 Agonists Be at Lower Risk of Prostate Cancer Aggressiveness and Progression?

Published in:

Cancers, 2025, v. 17, n. 9, p. 1576, doi. 10.3390/cancers17091576

By:

Drewa, Julia;
Lazar-Juszczak, Katarzyna;
Adamowicz, Jan;
Juszczak, Kajetan

Publication type:

Article

Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Cancer Prevention: Methodological Pitfalls in Observational Studies.

Published in:

Cancers, 2025, v. 17, n. 9, p. 1451, doi. 10.3390/cancers17091451

By:

Harris, Matthew;
Harvie, Michelle;
Renehan, Andrew G.

Publication type:

Article

Recent advances in targeting obesity, with a focus on TGF-β signaling and vagus nerve innervation.

Published in:

Bioelectronic Medicine, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s42234-025-00172-x

By:

John, Sahara;
Bhowmick, Krishanu;
Park, Andrew;
Huang, Hai;
Yang, Xiaochun;
Mishra, Lopa

Publication type:

Article

Luminal Sweet Sensing and Enteric Nervous System Participate in Regulation of Intestinal Glucose Transporter, GLUT2.

Published in:

Nutrients, 2025, v. 17, n. 9, p. 1547, doi. 10.3390/nu17091547

By:

Moran, Andrew W.;
Alrammahi, Miran;
Daly, Kristian;
Weatherburn, Darren;
Ionescu, Catherine;
Blanchard, Alexandra;
Shirazi-Beechey, Soraya P.

Publication type:

Article

Dietary Behaviors and the Living Environment Can Explain Residual Obesity Risk.

Published in:

Nutrients, 2025, v. 17, n. 9, p. 1413, doi. 10.3390/nu17091413

By:

Panagiotakos, Demosthenes

Publication type:

Article

Genetic Risk Score Identifies Individuals Likely to Report Adverse Events from GLP-1 Mimetic Therapy.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Tirzepatide Demonstrates Greater Weight Loss Than Semaglutide in Head-to-Head Study.

Published in:

2025

By:

Jennings, Sydney

Publication type:

Abstract

فراوانی عوارض دارویی و اپیزودهای هیپوگلیسمی در بیماران دیابتی نوع ۲ تحت درمان با داروهای نوین مراجعه کننده به بیمارستان امام خمینی ارومیه.

Published in:

Arak Medical University Journal, 2025, v. 28, n. 1, p. 43, doi. 10.61186/jams.28.1.43

By:

ابراهیم محمدی;
لعیا هوشمند;
آرش معصومی

Publication type:

Article

Influence of Combination Therapy with Dulaglutide or Liraglutide and SGLT2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Post-hoc Analysis of the RECAP Study.

Published in:

Tokai Journal of Experimental & Clinical Medicine, 2025, v. 50, n. 1, p. 1

By:

Yoshimi MUTA;
Kazuo KOBAYASHI;
Masao TOYODA;
Shunichiro TSUKAMOTO;
Daisuke TSURIYA;
Yuichi TAKASHI;
Hisashi YOKOMIZO;
Kei TAKESHITA;
Takuya HASHIMOTO;
Moritsugu KIMURA;
Kouichi TAMURA;
Keizo KANASAKI;
Daiji KAWANAMI

Publication type:

Article

JAMA Psychiatry—The Year in Review 2024.

Published in:

2025

By:

Öngür, Dost

Publication type:

Opinion

Activation of GLP-1R modulates the spontaneous discharge of nigral dopaminergic neurons and motor behavior in mice with chronic MPTP Parkinson's disease.

Published in:

Frontiers in Aging Neuroscience, 2025, p. 1, doi. 10.3389/fnagi.2025.1529919

By:

Liu, Wen-Hong;
Liu, Cui;
Xue, Yan;
Sun, Xiang-Rong;
Chen, Xin-Yi;
Chen, Lei

Publication type:

Article

Pre-immunization of diet-induced obese male mice with inactivated pathogens increases power in a liraglutide intervention study.

Published in:

Laboratory Animals, 2025, v. 59, n. 2, p. 203, doi. 10.1177/00236772241279058

By:

Falkenberg, Caroline;
Sørensen, Dorte B;
Hansen, Camilla HF;
Toft, Martin F;
Hansen, Axel K

Publication type:

Article

GLP-1 Agonists May Preserve Muscle Mass During Weight Loss: Daily Dose.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Influence of glucagon-like peptide-1 receptor agonists on renal parameters: a meta-analysis of randomized controlled trials.

Published in:

BMC Endocrine Disorders, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12902-025-01948-7

By:

Li, Wenjing;
Liang, Xiaoyan;
Sun, Na;
Zhang, Daqing

Publication type:

Article

Access to GLP-1s: Where Do Employers Fit in?

Published in:

American Journal of Health Promotion, 2025, v. 39, n. 5, p. 828, doi. 10.1177/08901171251335507a

By:

Imboden, Mary T.

Publication type:

Article

Glucagon-Like Peptide 1 Receptor Agonists and the Deepening Health Equity Divide in America.

Published in:

American Journal of Health Promotion, 2025, v. 39, n. 5, p. 832, doi. 10.1177/08901171251335507b

By:

Spinelli, Kateri J.;
Oakes, Allison H.

Publication type:

Article

Clinical Insights on Managing DPN and PAD in Patients with Diabetes.

Published in:: Primary Care Reports, 2025, v. 31, n. 4, p. 1
Publication type:: Article

The extent and predictors of off‐label use of GLP‐1 receptor agonists for weight loss management.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 6, p. 3509, doi. 10.1111/dom.16313

By:

Siudak, Zbigniew;
Tkaczyk, Filip;
Tomaszewska, Monika;
Malinowski, Krzysztof P.;
Szarpak, Lukasz;
Kowalska‐Bobko, Iwona

Publication type:

Article

Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity.

Published in:

Integrated Pharmacy Research & Practice, 2025, v. 14, p. 59, doi. 10.2147/IPRP.S503501

By:

Alzahrani, Abdullah M;
Alshobragi, Ghada A;
Alshehri, Abdullah M;
Alzahrani, Majed S;
Alshehri, Hasan A;
Alzhrani, Rami M;
Basudan, Samah;
Alkatheeri, Ayed A;
Almutairi, Salman A;
Alzahrani, Yahya A

Publication type:

Article

Hormonal Regulation in the Obese Population.

Published in:

Nutritional Perspectives: Journal of the Council on Nutrition, 2024, v. 47, n. 4, p. 16

By:

Bell, Michael T.

Publication type:

Article

GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.

Published in:

Acta Diabetologica, 2024, v. 61, n. 2, p. 225, doi. 10.1007/s00592-023-02184-y

By:

Li, Xiang;
Jiang, Xiao;
Jiang, Mei;
Wang, Zhi-feng;
Zhao, Tao;
Cao, Si-ming;
Li, Qiu-Mei

Publication type:

Article